Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
92.5M
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
34.1M
-
Shares change
-
+22.3M
-
Total reported value, excl. options
-
$68.3M
-
Value change
-
+$44.8M
-
Put/Call ratio
-
2.43
-
Number of buys
-
44
-
Number of sells
-
-11
-
Price
-
$2.00
Significant Holders of Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST) as of Q3 2025
73 filings reported holding MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value per share as of Q3 2025.
Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.1M shares
of 92.5M outstanding shares and own 36.92% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (6.98M shares), Propel Bio Management, LLC (5.12M shares), ORBIMED ADVISORS LLC (3.22M shares), MORGAN STANLEY (2.97M shares), Simplify Asset Management Inc. (2.83M shares), RTW INVESTMENTS, LP (2.51M shares), Pathstone Holdings, LLC (1M shares), SPHERA FUNDS MANAGEMENT LTD. (820K shares), TORONTO DOMINION BANK (750K shares), and Affinity Asset Advisors, LLC (667K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.